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Abstract
Activation of an acid sphingomyelinase (aSMase) leading to a biosynthesis of GD3 disialoganglioside has been associated
with Fas-induced apoptosis of lymphoid cells. The present study was undertaken to clarify the role of this enzyme in the
generation of gangliosides during apoptosis triggered by Fas ligation. The issue was addressed by using aSMase-deficient
and aSMase-corrected cell lines derived from Niemann-Pick disease (NPD) patients. Fas cross-linking elicited a rapid
production of large amounts of complex a- and b-series species of gangliosides with a pattern and a chromatographic
behavior as single bands reminiscent of brain gangliosides. The gangliosides were synthesized within the first ten minutes
and completely disappeared within thirty minutes after stimulation. Noteworthy is the observation that GD3 was not the
only ganglioside produced. The production of gangliosides and the onset of apoptotic hallmarks occurred similarly in both
aSMase-deficient and aSMase-corrected NPD lymphoid cells, indicating that aSMase activation is not accountable for
ganglioside generation. Hampering ganglioside production by inhibiting the key enzyme glucosylceramide synthase did
not abrogate the apoptotic process. In addition, GM3 synthase-deficient lymphoid cells underwent Fas-induced apoptosis,
suggesting that gangliosides are unlikely to play an indispensable role in transducing Fas-induced apoptosis of lymphoid
cells.
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Introduction
The cross-linking of the surface receptor Fas (CD95) triggers
apoptosis in a variety of cell types, which is associated with an
increase of intracellular ceramide levels [1–5]. On the other hand,
it has been shown that the synthesis and transient accumulation of
GD3 ganglioside is required for the progression of apoptotic
signals induced by anti-Fas antibodies [6,7] and membrane-
permeable ceramides [6,8] in lymphoid cells. GD3 results from the
addition of a second sialic acid to the one present on GM3,
mediated by the action of GD3 synthase (alpha-2,8-sialyltransfer-
ase), a transmembrane type II protein of about 40 kDa resident in
the early Golgi. A working model has been proposed in which
ceramide synthesis mediated by an acid sphingomyelinase
(aSMase) would induce the accumulation of the disialoganglioside
GD3 [9]. Indeed, Testi and co-workers claimed that Epstein-Barr
virus (EBV)-transformed lymphoblasts from Niemann-Pick disease
(NPD) patients, which have an inherited deficiency in aSMase
activity, displayed an impaired Fas-induced apoptosis and failed to
produce GD3, whereas aSMase-reconstituted NPD lymphoblasts
could accumulate GD3 and undergo efficient Fas-mediated
apoptosis [9]. Neosynthesized GD3 ganglioside is then thought
to mediate apoptosis by localizing in mitochondria [6,8]. These
phenomena could be prevented by blocking GD3 synthase
expression, indicating that its de novo synthesis is necessary [6].
Such a model has been mostly validated by data derived from the
addition of high concentrations of GD3 (in the form of micelles) to
cell culture suspensions incorporating subcellular organelles (e.g.,
mitochondria) with a wrong topology [10], or by in vitro
experiments on purified mitochondria.
Notwithstanding, conflicting reports have been published as for
the implication of aSMase in transducing death signals (see reviews
[11–13]) and in particular in the signaling of Fas-induced
apoptosis. Testi and co-workers have shown that NPD lympho-
blasts were resistant to Fas-induced apoptosis, and that recovery of
wild-type activity in cells (by addition of wild-type aSMase protein
to the incubation medium) restored the response to anti-Fas
antibodies [9]. In contrast, others have found no difference
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mediated restoration of wild-type aSMase gene), all being fully
sensitive to anti-Fas antibodies [14,15]. Furthermore, Green and
co-workers reported that primary cultures of lymphocytes derived
from aSMase-deficient (Smpd12/2) mice display no resistance to
anti-Fas antibody- or soluble Fas ligand-induced apoptosis [16].
These conflicting results have raised several issues that we
proposed to address in this study: (i) is indeed aSMase required to
produce GD3 during Fas-induced cell death? (ii) is GD3 the only
ganglioside produced in response to apoptotic stresses? and (iii) is
ganglioside synthesis either instrumental or a mere epi-phenom-
enon in the apoptotic process?
Materials and Methods
Reagents
Anti-Fas (clone CH-11) antibody was from Beckman-Coulter
(Roissy CDG, France). Murine FasL was produced in the
supernatant of Neuro-2A cells stably transfected with a plasmid
encoding FasL [17]. Recombinant human FasL was a kind gift
from Dr. P. Legembre (Rennes, France). C6-ceramide and D,L-
threo-1-phenyl-2-decanoylamino-morpholino-1-propanol (PDMP)
were from Biomol (Tebu International, Le Perray-en-Yvelines,
France). Alternatively, C6-ceramide was from Matreya (Pleasant
Gap, PA). N-butyldeoxynojirimycin (DNJ) was from Toronto
Research Chemicals (North York, Canada). RPMI 1640 medium,
antibiotics and fetal calf serum were purchased from Invitrogen
(Cergy-Pontoise, France). All solvents of analytical grade were
from Merck (Darmstadt, Germany) and other reagents were
obtained from Sigma (L’Isle d’Abeau, France). Radiolabelled
[choline-methyl-
14C]-sphingomyelin was from New England
Nuclear (Paris, France) and [ceramide-
3H]-sphingomyelin was
from CEA (Gif-sur-Yvette, France).
Cell culture
Epstein-Barr virus (EBV)-transformed B lymphocytes from
control individuals and from patients affected with NPD Type A
(cell lines Tre and Elg) have previously been described and
characterized with respect to sphingomyelin metabolism [15]. The
transformed B cells derived from a NPD Type B patient (line
MS1418), who is homozygous for a G to A nucleotide substitution
at position 1799 leading to p.R600H in the aSMase protein, and
the corresponding cell line transduced with an empty vector (cell
line MS14182) as well as the aSMase-transduced (cell line
MS1418+) MS1418 cells have previously been reported [14,15].
These cell lines were kindly provided by Dr. W. van Blitterswijk
(Amsterdam, The Netherlands). The RLS lymphoid cell line,
which is derived from a patient deficient for GM3 synthase activity
[18] (OMIM 609056) was a kind gift from Dr. H. Wang
(Middlefield, OH). Lymphoid cells were routinely grown in a
humidified 5% CO2 atmosphere at 37uC in RPMI 1640 medium
containing Glutamax (2 mmol/l), penicillin (100 U/ml), strepto-
mycin (100 mg/ml) and 10% heat-inactivated fetal calf serum
(FCS). Possible mycoplasma contaminations were monitored
regularly by PCR.
Flow cytometry analyses
Fas/CD95 cell surface expression was determined after
incubation of cells for 30 min at 4uC with or without anti-
CD95-phycoerythrin or an irrelevant antibody coupled to
phycoerythrin (Beckman-Coulter). To allow study of phosphati-
dylserine externalisation, cells were labeled with Annexin V-
fluorescein isothiocyanate (250 ng/ml) and propidium iodide
(12.5 mg/ml) (Abcys, Paris, France) for 10 min at 4uC. The level
of GM3 at the cell surface was examined on intact cells by using an
anti-GM3 antibody from Seikagaku (Coger, Paris, France).
Analyses were performed using a FACSCalibur flow cytometer
(BD Biosciences).
DNA sequencing
Total RNA was extracted from lymphoid cells and reverse-
transcribed using Superscript II (Invitrogen). Part of the ST3GAL5
(accession number NM_003896) cDNA encoding for GM3
synthase (E.C. number 2.4.99.9) was PCR-amplified using the
following primer pair: 2GM3S, 59-GGGCGCACCACTGTCT-
GACC-39 and 2GM3AS, 59-TCGGCCCCAGAACCTTGACT-
GA-39, and Phusion High-Fidelity DNA polymerase (Ozyme,
St-Quentin-en-Yvelines, France). Nucleotide sequencing was per-
formed by MilleGen (Labe `ge, France).
Cell viability assay and morphological analyses
Viability was evaluated by the tetrazolium-based MTT assay.
Cells were seeded in flat-bottomed 96-well plates for 24 or
48 hours at 37uC. 3-(4,5-Dimethylthiazol-2yl)-2,5-diphenyltetra-
zolium bromide (MTT, 0.5 mg/ml; Euromedex, Mundolsheim,
France) was added during 3 hours. Formazan crystals were
solubilized overnight at 37uC by adding 100 ml of solubilization
buffer (HCl 0.01N, 10% SDS) and spectrophotometrically
quantified using a microplate reader (wavelength=590 nm).
Apoptosis was assessed by Hoechst staining as described
previously [19]. The percentage of apoptotic cells was calculated
as the number of apoptotic cells per one hundred total cells
counted.
Fluorogenic DEVD cleavage enzyme assay
After treatment, cell pellets were homogenized in an aqueous
buffer made of 10 mM HEPES (pH 7.4), 42 mM KCl, 5 mM
Table 1. In vitro aSMase activity and lysosomal sphingomyelin turnover in cultured lymphoblasts.
Cell line aSMase activity Undegraded sphingomyelin
(nmol per hr/mg of protein) (% of total)
Control 3.2260.23 25
Tre 0.0260.01 95
MS1418 0.1060.01 90
Corrected MS1418+ 2.3060.20 35
Acid sphingomyelinase activity was determined on cell lysates using [choline-methyl-
14C]sphingomyelin. Undegraded sphingomyelin was measured after incubation of
intact cells with [ceramide-
3H]sphingomyelin (see [22]).
doi:10.1371/journal.pone.0019974.t001
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2 mg/ml leupeptin. Reaction mixtures contained 100 ml of cell
lysates and 100 mlo f4 0 mM Ac-Asp-Glu-Val-Asp-7-amino-4-
methylcoumarin (Ac-DEVD-AMC; Bachem, Voisins-le-Breton-
neux, France) [19]. After 30 min incubation at room temperature,
the amount of the released fluorescent product aminomethylcou-
marin was determined using a Jobin-Yvon spectrofluorometer (at
351 and 430 nm for the excitation and emission wavelengths,
respectively).
Western blot analysis for caspase-3 processing
Analysis of caspase-3 cleavage was carried out by Western blot
using the cell lysates prepared for DEVD cleavage enzyme assay as
previously described [19]. Rabbit anti-caspase-3 was a gift from
Dr. D. Nicholson (Merck-Frosst, Pointe-Claire, Quebec) or was
provided by Cell Signaling (Ozyme). Proteins were visualized by
ECL using anti-rabbit horseradish peroxidase-conjugated IgG
(Bio-Rad, Marnes-la-Coquette, France).
Quantitation of acid sphingomyelinase activity
Acid sphingomyelinase activity was determined as previously
described [20–22] using [choline-methyl-
14C]sphingomyelin
(120,000 dpm/assay; specific activity 54 mCi/mmol) as substrate.
Incubation of intact cells with radiolabelled
sphingomyelin
Cells were incubated at 37uC for 24 h with medium containing
10% fetal calf serum and [ceramide-
3H]sphingomyelin (10
6 dpm/
ml; specific activity 400 mCi/mmol) which was added as an
ethanolic solution [22]. The cells were then washed and the lipids
were extracted and resolved by analytical thin-layer chromatog-
raphy on plates migrated in chloroform/methanol/water
(100:42:6, by vol.). The distribution of the radioactivity on the
plates was analyzed using a Berthold LB2832 radiochromatoscan.
Unlabeled or radioactive lipid standards were used to identify the
various metabolic products.
Figure 1. Production of gangliosides in Niemann-Pick disease
lymphoid cells upon treatment with anti-Fas or C6-ceramide.
(a) Ganglioside production in Niemann-Pick lymphoblasts after
treatment with anti-Fas antibody (200 ng/ml) for 15 min. Ganglio-
sides were analyzed by HPTLC. The standard (Std) represents a
mixture of bovine brain and melanoma gangliosides. For each cell
line, the same number (50610
6) of untreated and anti-Fas-treated
cells was used. Lipids were extracted and loaded on the plate. (b)
MS1418 cells (25610
6) were incubated at 37uC for the indicated times
with anti-Fas (500 ng/ml). Then, gangliosides were extracted and
analyzed by HPTLC. Std represents standard gangliosides from
melanoma (Mel.) or bovine brain. (c)T r eN P Dl y m p h o b l a s t s
(25610
6) cells were treated for 10 min at 37uCw i t h5 0mMo fC 6-
ceramide dissolved in ethanol. Then, gangliosides were purified and
analyzed by HPTLC.
doi:10.1371/journal.pone.0019974.g001
Figure 2. Thin-layer chromatography immunostaining with a
mixture of anti-GM3, anti-GM2 and anti-GM1 Mabs of gangli-
osides of Tre and MS1418+ cell lines after 10 min treatment
with anti-Fas. Std represents standard gangliosides from bovine brain.
The amounts of gangliosides applied on the HPTLC plate were one
tenth of those visualized by resorcinol-HCl in Fig. 1a.
doi:10.1371/journal.pone.0019974.g002
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As the incubation times with apoptogenic agents were short, the
treatment with such agents was carried out in phosphate-buffered
saline pH 7.4 (PBS). In typical experiments, 5.10
7 cells were
washed with buffer by centrifugation at 1000 rpm in round-
bottomed 30 ml centrifuge tubes, taken up in 1 ml of buffer and
kept at 37uC for 15 min prior to the addition of anti-Fas or C6-
ceramide. The cellular metabolism was stopped by the addition of
20 ml of chloroform-methanol 1:1 (v/v) and the lipids were
extracted by stirring 3 h at 37uC. After centrifugation, the clear
supernatants were transferred to flasks and evaporated to dryness
at 40uC in a rotary evaporator (Bu ¨chi, Zurich, Switzerland). The
lipids were dissolved in chloroform/methanol (1:1), filtered to
remove any non-soluble material, and partitioned three times in
chloroform/methanol/PBS (1:1:0.7, by volume) as previously
reported [23]. The gangliosides were recovered from the pooled
upper phases by reverse-phase chromatography on styrene-
divinylbenzene copolymer columns (Envi-Chrom
TM, Supelco,
L’Isle d’Abeau, France) as described by Popa et al. [24]. The
gangliosides were quantitated by the periodate-resorcinol method
[25] and migrated on high performance thin-layer chromatogra-
phy (HPTLC) plates in chloroform/methanol/0.2% CaCl2
(60:35:8, by volume) along with known standards. Gangliosides
species were identified by immunostaining on thin-layer plates as
described [26] using the following monoclonal antibodies (Mabs) :
4E6 specific for GD3, GMR28 directed to GM2 (gift from Dr.
Tadashi Tai, Tokyo Metropolitan Institute of Medical Science,
Tokyo, Japan) and E1 reacting with GM1 (kindly provided by Dr.
M. Alfonso, Center of Molecular Immunology, Havana, Cuba).
The lower phases of partition were evaporated to dryness under
nitrogen, taken up in chloroform and the lipid classes were
separated by column chromatography on aminopropyl silica gel
cartridges (LC-NH2, Supelco) according to Bodennec et al. [27].
Statistical analyses
Data are presented as means 6 S.E.M. The Student’s t-test was
used for statistical analysis (*, p,0.05; **, p,0.01).
Results
Fas cross-linking and exogenous ceramide treatment
trigger different ganglioside production in normal as well
as Niemann-Pick disease lymphoid cells
We have investigated the generation of gangliosides in EBV-
transformed lymphoblasts derived from control subjects and
patients affected with NPD type A (the most severe form of
NPD) [15]. Among these cell lines, we have used the MS1418 cell
line deficient in aSMase activity [28], as well as the MS1418+ cell
line that re-expresses aSMase after retrovirus-mediated gene
transfer (Table 1) [14].
The production of gangliosides was analyzed after Fas ligation
by thin-layer chromatography. As illustrated in Fig. 1a, Niemann-
Pick lymphoblasts (MS1418 and Tre cell lines) synthesized within
5 to 15 min several new species of gangliosides of the A-series
(GM2, GM1, GD1a) with a whole ganglioside pattern reminiscent
of that in brain [29]. Identification of gangliosides was carried out
by immunostaining on thin-layer plates [26] after migration of the
gangliosides, using a mixture of monoclonal antibodies known to
react respectively with GM3, GM2 and GM1 as shown in Fig. 2.
Identification of the other species, done by co-migration with
authentic standards, indicated the presence of GD1a, GD1b, and
GT1b, GD3 not being anymore the predominant ganglioside. An
intriguing feature was the migration of these additional ganglio-
sides as single bands (see also the lane of standards in Fig. 1a)
instead of the doublets that can be seen with GM3 and GD3 as in
untreated cells. Single bands of gangliosides from normal human
tissues are usually seen only with brain and red cells. It should be
noted that GM3 level was not affected by anti-Fas treatment,
suggesting that the generation of complex gangliosides did not
originate from the pre-existing GM3 pool (Fig. 1a).
Interestingly, the aSMase-transduced NPD (line MS1418+)
ganglioside pattern after anti-Fas treatment was comparable to
that of the untransduced MS1418 NPD cell line (Fig. 1a). The
ganglioside generation was quantitatively very important, up to
50-fold above the control, but it was transient as most of the
neosynthesized gangliosides disappeared after 30 min and the
ganglioside pattern was back to normal within 60 min beyond
treatment (Fig. 1b). In addition, ganglioside production was also
observed when cells were treated with exogenous C6-ceramide
(Fig. 1c). An interesting observation is that, after anti-Fas or cell-
permeable ceramide treatment, EBV-transformed lymphoblasts
derived from control subjects showed a rapid synthesis of
gangliosides, but the increase involved mostly the GM3 and
GD3 ganglioside species already found in the control cells, in
striking contrast with the ganglioside profile seen with NPD cells
(see Fig. 3a). This different response in the ganglioside species
neosynthesized between control and aSMase-deficient (but also
aSMase-transduced) cell lines is not yet understood. It is
noteworthy to point out that increased levels of the lactosylcer-
amide precursor were seen concomitantly with the rapid increase
in ganglioside biosynthesis (see Fig. 3c).
Notwithstanding, our data markedly differ from those previ-
ously published [6,9] as i) Niemann-Pick lymphoblasts are fully
capable of producing GD3, and ii) GD3 is far from being the
unique ganglioside produced during Fas-induced apoptosis.
Fas cross-linking and exogenous ceramide treatment
induce apoptosis, and caspase-3 activation analogously
in normal and Niemann-Pick disease lymphoid cells
We next compared the sensitivity to apoptosis of the NPD
lymphoid cells. As we have previously reported [15], treatment
with anti-Fas antibody induced apoptosis equally well in control,
NPD (MS1418 and Tre cell lines), and corrected NPD MS1418+
cell line (Fig. 4a). We also examined whether aSMase influenced
Figure 3. Pharmacological inhibition of ganglioside production does not prevent from anti-Fas-induced apoptosis. (a) Production of
gangliosides in control lymphoblasts after treatment with 200 ng/ml anti-Fas antibody for 10 min with or without pre-treatment with 10 mM PDMP.
Melanoma (Mel. Std) and bovine brain (Brain Std) ganglioside mixtures were used as standards. (b) Effect of PDMP on the production of gangliosides
by NPD (MS1418) cells that were incubated as described in (a). (c) Effect of PDMP on the production of neutral glycosphingolipids by NPD (MS1418)
cells that were incubated as described in (a). GlcCer, glucosylceramide; LacCer, lactosylceramide. (d) Control (Con) and NPD lymphoblasts were pre-
incubated for 24 h with or without 10 mM PDMP or 400 mM DNJ, and treated without or with 100 ng/ml anti-Fas antibody for 5 h under serum-free
conditions. Cell surface exposure of phosphatidylserine was determined by flow cytometry using annexin V-FITC/PI labelling (ns, not significant).( e)
Control (Con), NPD (MS1418) and aSMase-transduced NPD (MS1418+) cells were incubated as indicated in (d) and cell extracts were subjected to 15%
SDS-PAGE and immunoblotted with anti-caspase-3 antibody. Migrations indicated are: pro-caspase-3, full-length inactive caspase-3; p20 and p17,
active subunits.
doi:10.1371/journal.pone.0019974.g003
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PLoS ONE | www.plosone.org 5 May 2011 | Volume 6 | Issue 5 | e19974Figure 4. Control and Niemann-Pick disease lymphoblasts are equally sensitive to anti-Fas-induced apoptosis. (a) Control, NPD
(MS1418 and Tre cell lines), and aSMase-transduced NPD (MS1418+ cell line) lymphoblasts were incubated in serum-free conditions with or without
100 ng/ml anti-Fas for 5 h. The percentage of apoptotic cells was evaluated by the DNA-specific fluorochrome Hoechst 33258. Nuclei were visualized
by fluorescence microscopy, and a minimum of 300 cells were scored. Mean values and standard deviations for each sample from at least three
different experiments are shown. (b) DEVDase activity was measured with the fluorogenic substrate Ac-DEVD-AMC in extracts from NPD (MS1418 and
Tre cell lines), and the aSMase-transduced NPD (MS1418+ cell line) lymphoblasts treated for the indicated times without (open squares) or with
100 ng/ml anti-Fas antibody (filled squares). Results are means 6 S.D. of at least three independent experiments. (c) Extracts from control, NPD
(MS1418 and Tre cell lines), and aSMase-transduced NPD (MS1418+ cell line) lymphoblasts treated with anti-Fas antibody for 5 h were subjected to
15% SDS-PAGE and immunoblotted with anti-caspase-3 antibody. Migrations indicated are: pro-caspase-3, full-length inactive caspase-3; p20 and
p17, active subunits.
doi:10.1371/journal.pone.0019974.g004
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proteases that drive the effector phase of apoptosis, and which are
activated during Fas-induced apoptosis. To monitor executioner
caspase activity, we utilized the fluorogenic substrate, Ac-DEVD-
AMC, which corresponds to the cleavage site found in various
caspase-3 and -7 targets. In control, NPD MS1418 and corrected
NPD MS1418+ cell lines, we observed similar time-dependent
increases in DEVDase activity (Fig. 4b) that correlated with the
onset of apoptosis. Proteolytic cleavage of caspase-3 was also
examined by Western blotting, and Fig. 4c illustrates the
processing of caspase-3 into its respective active forms regardless
of the aSMase status of the cell lines used. These findings clearly
indicate that normal and NPD lymphoblast cells are equally
sensitive to Fas-induced apoptosis. Similar results were found
when cells were treated with exogenous C6-ceramide (data not
shown).
Blocking ganglioside production does not abrogate
apoptosis induced by Fas ligation in both normal and
Niemann-Pick disease lymphoid cells
Thereafter, in order to establish the relevance of ganglioside
production during Fas-induced apoptosis in NPD lymphoblast
cells, we decided to study the effect on apoptosis of two specific
inhibitors of glucosylceramide synthase, PDMP and DNJ [30,31].
As shown in Table 2, incubation of the Tre NPD cell line with
DNJ and PDMP raised the intracellular concentration of ceramide
to the detriment of endogenous glucosylceramide. Similar results
were found with the other cell lines tested regardless of the aSMase
status.
As expected, the ganglioside profile was markedly altered when
cells were pretreated with PDMP. As illustrated in Fig. 3a, there
was indeed a strong reduction in ganglioside generation upon Fas
ligation in control lymphoblasts pre-incubated with 10 mM
PDMP. NPD and reconstituted NPD lymphoblasts (MS1418
and MS1418+ cell lines, respectively) exhibited a similar profile
(Fig. 3b). Comparable findings were also observed when
glucosylceramide synthase was inhibited by DNJ (data not shown).
Both the increase of the ganglioside precursor lactosylceramide
(Fig. 3c) and GD3, following anti-Fas treatment, were completely
abolished by PDMP.
In addition, pre-treatment with PDMP or DNJ did not impede
Fas-induced apoptosis as evidenced by the assessment of
phosphatidylserine translocation (Fig. 3d) as well as by the
processing of executioner caspase-3 which underwent efficiently
despite the inhibition of glycosphingolipid synthesis (Fig. 3e). These
results clearly show that inhibition of glucosylceramide synthase
does not confer resistance to Fas-mediated apoptosis in lympho-
blasts, and strongly suggest that gangliosides are unlikely to play a
role in transducing this apoptotic signal.
Finally, the susceptibility of GM3 synthase-deficient cells to Fas-
induced cell death was investigated. For this purpose, lymphoid
cells from a patient with a genetic deficiency of ganglioside GM3
synthase activity [18] were used. Analysis of the cDNA encoding
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 gene (ST3GAL5
or SIAT9) showed homozygosity for the c.862C.T nonsense
mutation which produces a premature termination codon at
position R288 (Fig. 5a). This genetic defect was accompanied by
the absence of detectable GM3 as evaluated by thin-layer
chromatography of total cellular lipids (Fig. 5b); similar results
were obtained by measuring the expression of GM3 at the cell
surface using flow cytometry (Fig. 5d). Of note, the cell surface
expression of the Fas/CD95 receptor remained unaltered (Fig. 5c).
When these and control lymphoblasts were challenged with
either murine or human FasL, no significant difference in loss of
cell viability was seen (Figs. 6a and 6d). As a control condition,
incubation of mutant and control cells with staurosporine, a
protein kinase inhibitor triggering the mitochondrial pathway of
apoptosis, resulted in similar cytotoxic effects (Fig. 6f). However,
phosphatidylserine translocation evaluated as a feature of
apoptosis was less prominent in the GM3 synthase-deficient
lymphoblasts than in control cells (Figs. 6b and 6e). Nevertheless,
caspase-3 processing was clearly activated in the mutant cell line as
evidenced by the appearance of cleaved forms (Fig. 6c).
Discussion
Fas-induced activation of an aSMase leading to generation of
GD3, a glycolipid (possibly also mitochondrial) raft constituent,
has been associated with apoptosis of lymphoid cells [6,9,32]. It
has been suggested that activation of this aSMase would induce
the accumulation of GD3, which in turn would mediate apoptosis
by targeting mitochondria [6,8,9]. Nevertheless, aSMase involve-
ment in Fas-induced apoptosis is still controversial. Whereas some
authors reported that NPD lymphoblasts are resistant to Fas-
mediated cell death [9], others have found no differences [14,15].
In addition, thymic cells from Smpd12/2 mice display no
resistance to apoptosis in vivo or ex vivo supporting the notion that
aSMase is not necessary to mediate apoptosis in lymphoid cells
[16] [11,12,28]. Our studies confirm previous results [14,15] that
Fas cross-linking trigger similar apoptotic hallmarks in normal and
aSMase-deficient cell lines.
The present findings show that, at least in lymphoid cells, Fas
can indeed trigger the production of gangliosides but this
production is not requisite for induction of cell death. Such a
generation of gangliosides appeared i) to be an early event
(occurring within the minutes following Fas ligation), ii) to involve
several gangliosides, not only GD3, iii) to rely on the ceramide to
glucosylceramide conversion, and iv) to involve the entire pathway
of glycosylation since the levels of the ganglioside precursor
lactosylceramide also increased along with gangliosides. The
present observations also demonstrate that aSMase activation is
not accountable for ganglioside generation in cultured lympho-
blasts as originally described [6,9].
Of importance is the observation that GD3 was not the only
ganglioside produced upon Fas ligation. Conversely, we found
within a few minutes an accumulation of b-series (e.g., GD1b and
GT1b) as well as a-series (e.g., GM1a and GD1a) gangliosides (see
Table 2. Neutral sphingolipid percent distribution in NPD Tre
cells pre-incubated with the indicated concentrations of NDJ
or PDMP.
Neutral sphingolipid (% of total)
Glucosylceramide Ceramide
Untreated 54 41
DNJ (100 mM) 19 78
DNJ (200 mM) 14 83
DNJ (400 mM) 10 88
PDMP (10 mM) 8 90
PDMP (20 mM) 7 90
PDMP (40 mM) 7 92
Lipids were separated by HPTLC and their concentrations were determined
after acid hydrolysis using fluorescamine as previously described [37].
doi:10.1371/journal.pone.0019974.t002
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pathways of gangliosides), demonstrating that GalNAc-transferase
and other transferases are present, but normally inactive in these
cells. It should be pointed out that the relevant hydrolases also
should be present in cells but in the inactive form since all de novo
synthesized gangliosides totally disappeared in less than one hour.
No traces of gangliosides was found in the buffer, thus ruling out
any shedding to explain this rapid disappearance.
Figure 5. Characterization of the GM3 synthase-deficient lymphoid cell line. (a) Sequencing of the ST3GAL5 cDNA prepared from control
(Con) and the RLS (GM3 synthase-deficient) cell lines. The arrow indicates the c.862C.T point mutation. (b) HPTLC analysis of gangliosides isolated
from control (Con), the RLS and Elg (NPD type A) cell lines. GM3 was used as a standard lipid. (c) Cell surface expression of Fas/CD95. Intact control
(Con), RLS and Tre (NPD type A) cell lines were incubated with an anti-CD95 (green line) or an irrelevant (black line) antibody. Labelling was evaluated
by flow cytometry. (d) Cell surface expression of GM3 in control (Con) and RLS lymphoblasts, as evaluated by flow cytometry. Control murine
melanoma (B16 cell line) and glucosylceramide synthase-deficient murine melanoma (GM95) cells were used as controls.
doi:10.1371/journal.pone.0019974.g005
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to block the synthesis of complex gangliosides and results in the
expression of the simple gangliosides GM3 and GD3. Despite the
enormous amounts of GM3 and GD3 accumulated, these mutants
are viable, with a normal life span and a central nervous system
that is largely intact both morphologically and functionally
[34,35]. Furthermore, GD3 synthase-deficient (St8sia1 knockout)
mice that are devoid of the b-series structures, including GD3,
Figure 6. Susceptibility of GM3 synthase-deficient lymphoid cells to apoptosis inducers. (a–c), Control (Con; 3 different cell lines) and RLS
(GM3 synthase-deficient) cells were treated with 1 mg/ml mFasL. After 24 or 48 h incubation, cell viability was assessed by the MTT test (a) or cell
surface exposure of phosphatidylserine was determined by flow cytometry after a 24 h incubation (b). Data are means 6 SEM of at least 3
determinations. Alternatively, processing of caspase-3 was monitored by Western blot after the indicated time of incubation (c). (d) and (e), Control
and RLS cells were incubated for 16 h with 1 mg/ml hFasL. Then, cell viability (d) and cell surface exposure of phosphatidylserine (e) were determined.
Data are means 6 SEM of at least 3 determinations. Note that, for (b) and (e), comparable results were obtained when analyzing the annexin V-
positive PI-negative cell population. (f), Cell viability of lymphoid cells after treatment for 24 h with 100 nM of staurosporine (STS).
doi:10.1371/journal.pone.0019974.g006
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gangliosides such as GM2, GM1 and GD1a [29,36]. These b-
series ganglioside-lacking mice are viable, have normal growth,
and do not exhibit gross behavioral abnormalities [29,36]. More
importantly, thymocytes from the wild-type and the GD3
synthase-deficient mice were used for the induction of apoptosis
by anti-Fas antibody, but no reduction in the sensitivity to Fas-
induced apoptosis could be detected [29]. Hence, deletion of the
b-series gangliosides including GD3 does not seem to alter Fas-
induced apoptosis in thymocytes clearly arguing against a role for
GD3 in mediating Fas-induced apoptosis. In agreement, we have
found that blockade of ganglioside production by inhibiting
glucosylceramide synthase by PDMP or DNJ does not impede
apoptosis.
Furthermore, cells that are genetically unable to synthesize
GM3 (and more complex gangliosides) underwent Fas-induced
effector caspase activation and cell death. Nonetheless, because
these mutant cells exhibited less phosphatidylserine exposure than
the control cell lines, the possibility that (GM3) gangliosides are
somehow involved as key plasma membrane constituents in this
phenomenon and the overall response to Fas ligation cannot be
ruled out. In addition, the possibility that such a behavior is
restricted to this particular mutant cell line (but not present in
other GM3 synthase-deficient cell lines) cannot be excluded as
some interindividual variations between control cell lines in the
degree of sensitivity to Fas-induced toxicity were observed (data
not shown).
In summary, the present investigation suggests that aSMase is
not required for production of GD3 and that gangliosides do not
play an essential role in transducing Fas-induced apoptosis of
cultured lymphoblasts. The data presented here clearly question
the current model for the transduction of apoptosis by which the
Figure 7. Schematic view of ganglioside biosynthesis in mammalian cells. Sequential addition of sialic acid residues to lactosylceramide
(LacCer) by the specific sialyl-transferases I, II and III produces the monosialo, disialo and trisialo-gangliosides GM3, GD3 and GT3, respectively. These
glycolipids serve as precursors for the a, b and c series of gangliosides, which are formed by stepwise glycosylation, i.e., by addition of N-acetyl-beta-
galactosamine (GalNAc), beta-galactose (Gal) and sialic acid by a GalNAc-transferase, a galactosyl-transferase and a sialyl-transferase, respectively.
doi:10.1371/journal.pone.0019974.g007
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PLoS ONE | www.plosone.org 10 May 2011 | Volume 6 | Issue 5 | e19974ganglioside GD3 would mediate Fas-induced apoptosis in
lymphoblasts. An intriguing finding of our study is the capacity
of NPD-derived lymphoid cells to synthesize during apoptosis
several ganglioside species that are usually not seen during the
normal life span of those cells.
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